Radnor Capital Management LLC Buys 299 Shares of Cardinal Health, Inc. (NYSE:CAH)

Radnor Capital Management LLC raised its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 14.2% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 2,409 shares of the company’s stock after purchasing an additional 299 shares during the period. Radnor Capital Management LLC’s holdings in Cardinal Health were worth $266,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Avidian Wealth Enterprises LLC boosted its stake in shares of Cardinal Health by 4.6% in the third quarter. Avidian Wealth Enterprises LLC now owns 6,114 shares of the company’s stock worth $676,000 after acquiring an additional 269 shares during the period. HF Advisory Group LLC boosted its stake in shares of Cardinal Health by 8.4% in the third quarter. HF Advisory Group LLC now owns 8,597 shares of the company’s stock worth $950,000 after acquiring an additional 663 shares during the period. NorthRock Partners LLC bought a new position in shares of Cardinal Health in the third quarter worth about $537,000. QRG Capital Management Inc. boosted its stake in shares of Cardinal Health by 83.3% in the third quarter. QRG Capital Management Inc. now owns 30,135 shares of the company’s stock worth $3,331,000 after acquiring an additional 13,697 shares during the period. Finally, Vestor Capital LLC boosted its stake in shares of Cardinal Health by 197.0% in the third quarter. Vestor Capital LLC now owns 158,508 shares of the company’s stock worth $17,518,000 after acquiring an additional 105,131 shares during the period. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of CAH stock opened at $118.22 on Friday. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $119.58. The stock’s 50 day simple moving average is $112.07 and its two-hundred day simple moving average is $104.41. The company has a market cap of $28.61 billion, a PE ratio of 23.00, a price-to-earnings-growth ratio of 1.39 and a beta of 0.60.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The business had revenue of $52.28 billion for the quarter, compared to the consensus estimate of $50.90 billion. During the same period in the prior year, the business posted $1.73 earnings per share. The company’s quarterly revenue was down 4.3% compared to the same quarter last year. Equities research analysts expect that Cardinal Health, Inc. will post 7.84 EPS for the current year.

Cardinal Health Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be given a dividend of $0.5056 per share. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $2.02 dividend on an annualized basis and a yield of 1.71%. Cardinal Health’s dividend payout ratio (DPR) is presently 39.30%.

Wall Street Analyst Weigh In

CAH has been the subject of a number of recent analyst reports. Barclays upped their price objective on Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a research note on Monday. Deutsche Bank Aktiengesellschaft upped their price objective on Cardinal Health from $119.00 to $124.00 and gave the stock a “hold” rating in a research note on Monday. UBS Group upped their price objective on Cardinal Health from $134.00 to $139.00 and gave the stock a “buy” rating in a research note on Monday. Robert W. Baird increased their price target on Cardinal Health from $130.00 to $137.00 and gave the company an “outperform” rating in a research note on Thursday, August 15th. Finally, Wells Fargo & Company increased their price target on Cardinal Health from $95.00 to $101.00 and gave the company an “underweight” rating in a research note on Thursday, August 15th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $123.00.

Insider Transactions at Cardinal Health

In related news, CFO Aaron E. Alt sold 2,323 shares of the firm’s stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $108.91, for a total transaction of $252,997.93. Following the completion of the sale, the chief financial officer now directly owns 36,867 shares of the company’s stock, valued at approximately $4,015,184.97. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CFO Aaron E. Alt sold 2,323 shares of the firm’s stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $108.91, for a total transaction of $252,997.93. Following the completion of the sale, the chief financial officer now directly owns 36,867 shares of the company’s stock, valued at approximately $4,015,184.97. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Michelle D. Greene sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $108.85, for a total value of $435,400.00. Following the sale, the insider now directly owns 19,242 shares of the company’s stock, valued at $2,094,491.70. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 113,963 shares of company stock worth $12,379,980. 0.09% of the stock is currently owned by company insiders.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.